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Abstract 
Cardiovascular diseases are a major problem nowadays and their 
incidence is only increasing. Fruits and vegetables have long been known 
to have antioxidant properties, but recently chocolate has been the focus 
of much research as cocoa appears to have similar qualities. Theobroma 
cacao, the plant that cocoa is derived from has been found to be a rich 
source of flavanols, which may protect against cardiovascular diseases. A 
literature review was carried out and the main ways in which chocolate 
may contribute to cardiovascular health are presented; these are the 
antioxidant, anti-inflammatory, and anti-platelet effects. The lipid profile 
may also be affected but is still a current topic of debate. The modes of 
action of the flavanols are summarised, but they are still hypotheses and 
the exact mechanisms are still unknown. Nevetheless the vast amount of 
epidemiological evidence suggests a definite link between cocoa from 
chocolate and cardiovascular health. As chocolate is a popular product 
sold worldwide, greater research into this area will definitely be beneficial. 
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1. Introduction 
Chocolate is a well-known, popular food all around the world, and is 
unique in that it is solid at room temperature yet easily melts in the mouth. 
Although it is usually sweet and quite calorific, recent studies have shown 
epidemiological links between the flavanols in chocolate and 
cardiovascular health. Flavanols are also found in fruit, vegetables, tea and 
red wine, but cocoa contains much more per weight (Lee et al 2003). The 
exact mechanism of the flavanols and metabolism of chocolate is still 
unknown, but we know that flavanols have antioxidant, anti-inflammatory 
and anti-platelet effects which assist in healthy endothelial function, and 
subsequently cardiovascular health. The aim of this paper is to present the 
current hypotheses relating to the mechanisms of the flavanols in 
chocolate, as well as any other benefits that it may have. 
 
2. Method 
As research into the link between chocolate and cardiovascular health is a 
very current, effort was put into using literature that was published as 
recently as possible. The majority are peer-reviewed journal articles. 
Articles published in the last 10 years were focused on, but sometimes the 
author referred to works created more than 10 years ago, and those were 
still used unless newer articles showing different results were found. 
Government websites were used for information regarding specific 
regulations on chocolate, and the World Health Organisation (WHO) 
website was used for official statistics relating to cardiovascular diseases. 
 
3. Brief background of chocolate 
3.1 History 
Chocolate is a popular food that is available all over the world now, but 
has its roots in Central and South America. It comes from the plant 
Theobroma cacao native to the Americas. The original method of 
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consumption of the cocoa bean however, was very different from what we 
have today. The Aztecs and Mayans consumed it as a bitter drink with the 
addition of spices, and it was considered a drink of the Gods (Engler & 
Engler 2006). The Spanish brought cocoa to Europe, but it did not become 
a mainstream item until the Industrial Revolution in the late 18th Century, 
when the development of mass production techniques lowered the cost of 
production. The first solid chocolate was produced in England in 1847, and 
slowly gained popularity until its sales overtook that of drinking chocolate 
(Ciddell & Alberts 2006). Solid chocolate is the type most frequently 
consumed now with a variety of additional ingredients used, for example 
nuts and raisins. Dark, milk and white chocolate are the three common 
types of chocolate, but white chocolate does not contain any cocoa mass, 
only the cocoa butter. Surveys have found that milk chocolate is the most 
popular in Europe, the UK and the USA. Also 87% of chocolate 
consumption in the USA is not through ‘pure’ chocolate, but that 
combined with nuts, caramel, wafers etc. (Vinson et al 2006). 
3.2 Basic components and production process 
There is a huge variety of chocolate available on the market nowadays, but 
they mostly consist of the basic ingredients cocoa mass, cocoa butter, 
sugar and milk. Today nearly half of the world’s supply of cocoa beans is 
grown in the Ivory Coast, with the rest being from Ghana and other African 
nations, Indonesia and some other Asian nations, and a small percentage 
from Latin America (Ciddell & Alberts 2006).  
Ground-up cocoa beans are known as cocoa liquor and contain 
approximately 55% cocoa butter. Cocoa, cocoa mass or cocoa powder 
refers to the non-fat component of the cocoa liquor (Cooper et al 2008). 
In the general process the cocoa beans are first fermented and dried, then 
undergo a process known as winnowing where the outer shell are 
removed leaving the cocoa nib. The nibs are ground up and separated into 
cocoa mass and cocoa butter. A small amount of the cocoa butter, sugar, 
vanilla and often an emulsifier lecithin are added to the cocoa mass, and 
undergo the conching process to remove bitterness and refine the texture 
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(Torres‐Moreno et al 2012). Depending on country regulations and 
individual manufactures, conching can take up to 72 hours or it may not 
take place at all. 
The proportion of each ingredient used and general processes must 
comply with regulations set by governing bodies in each country. For 
example the EU only allows up to 5% of the fat content to consist of non-
cocoa butter, and it must be one of the substitutes they have chosen. Any 
nut varieties added to the chocolate must not exceed 60% of the total 
weight of the product, and any products that do not meet the criteria are 
not allowed to be sold as ‘chocolate’, ‘dark chocolate’ etc. There is a type 
of milk chocolate in the UK and Ireland that contains 20% cocoa solids, but 
as the minimum EU requirement is 25% cocoa solids it must be sold under 
the name ‘Family Milk Chocolate’ elsewhere in the EU (CBI 2012). The FDA 
in the USA defines ‘milk chocolate’ as containing as least 10% cocoa liquor, 
but interestingly has no definition for ‘dark chocolate’ (FDA 2012). 
 
4. Cardiovascular Diseases 
4.1 What are cardiovascular diseases? 
Cardiovascular diseases (CVD) are major causes of death around the world, 
and are especially prominent in medium-low income earners. In 2008 17.3 
million people died from CVD (30% of global deaths) and an estimated 
23.6 million will die from it in 2030 (WHO 2012).  
CVDs are diseases affecting the heart and blood vessels. There are several 
types depending on where the affected vessel supplies blood to and where 
the blood clot occurs, whether it existed at birth, and whether it was 
caused by infection. The most prominent of these is coronary heart 
disease (CHD), damage in the vessels supplying blood to the heart muscle. 
There are many risk factors for CVD: smoking, obesity, diabetes and family 
history just to name a few. One of the underlying causes of CVD is 
atherosclerosis; the accumulation of modified low density lipoproteins 
(LDL) in the arterial walls causing plaque formation and blockage of blood 
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flow. Atherosclerosis can develop through oxidative stress, especially from 
LDL oxidation. LDL particles consist of around 2700 fatty acids, and about 
half of these are polyunsaturated and susceptible to oxidation. Oxidation 
is the addition of oxygen and greatly affects the activity of the particle. 
Oxidised LDL can inhibit the exit of macrophages while recruiting 
circulating monocytes, causing the formation of foam cells-sticky cells 
which accumulate inside the arterial wall. It can also reduce the 
bioavailability of NO causing endothelial dysfunction, and eventually cause 
strokes and heart attacks (Honarbakhsh & M. Schachter 2008). 
4.2 Evidence of association of chocolate with CVD 
A study looking at CHD found that consumption of chocolate five or more 
times a week, resulted in a 57% lower prevalence of CHD compared to 
those who never ate chocolate regardless of risk factors involved (Djoussé 
et al 2011). Another study focused on calcified atherosclerotic plaque in 
coronary arteries (CAC) in people who ate chocolate two or more times a 
week, once a week, one-three times a month and never. Results showed 
lower prevalence of CAC the more frequent chocolate consumption is. 
Lower systolic and diastolic blood pressures were also observed (Djoussé 
et al 2011).   
A study using rabbits with artherosclerosis found that cocoa powder 
inhibited the development of artherosclerotic lesions (Kurosawa et al 
2005). After six months, the area of artherosclerotic lesions was over 20% 
lower in rabbits that regularly consumed cocoa powder.  
These are not the only examples, but the majority of studies are only 
carried out in vitro or in vivo on healthy individuals, so more research 
needs to be undertaken involving individuals with CVD or at least some of 
the risk factors to show the direct correlation. 
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5. Flavanols and their effects 
5.1 What are flavanols? 
The polyphenols is a large class of compounds that act as antioxidants. A 
subclass, the flavonoids have been associated with various health benefits, 
and the flavanols or flavan-3-ols in particular have been linked to 
cardiovascular health. Procyanidins are the main type of oligomeric 
flavanols and are composed of the monomers collectively known as 
catechin, shown in Figure 1. The catechin molecule consists of three rings, 
two of which are benzene rings (rings A and B). It has two chiral centres at 
carbons 2 and 3, meaning four diastereoisomers; (+)-catechin, (-)-catechin, 
(+)-epicatechin and (-)-epicatechin. The most common in cocoa are (+)-
catechin and (-)-epicatechin and have been the focus of research. 
 
Figure 1: Basic structure of catechin (Tomoyo Oyama) 
 
5.2 Antioxidant effect 
All polyphenols have been found to have antioxidant activities in vitro, so 
now studies are being conducted to see whether this is the case in vivo. 
Various studies have shown chocolate to have antioxidant effects through 
the inhibition of LDL oxidation and increase in total antioxidant capacity 
(TAC). 
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The antioxidant effect was found to be dose-dependent, with a higher 
antioxidant capacity in chocolate with a higher cocoa solid content 
(Belščak-Cvitanovic et al 2011). In vivo experimentation has shown an 
increase in plasma antioxidant capacity after just a single dose of 100g of 
dark chocolate (Serafini et al 2003). Lettieri-Barbato et al (2012) found 
that the TAC of both dark chocolate and high antioxidant dark chocolate 
peaked 2 hours after ingestion. However the TAC of the high antioxidant 
dark chocolate remained relatively high even 5 hours after ingestion, while 
that of the other went down to zero. The inhibition of LDL peroxidation 
has been found in numerous studies, usually through the measurement of 
TBARS post-consumption (Mursu et al 2004, Mathur et al 2002, Vinson et 
al 2006). 
 
Although the exact mechanism is unknown there are some possible 
explanations. Figure 1 shows that catechin molecules have a 
dihydroxylated B ring. This allows for the rapid donation of hydrogen to 
stabilise radical species (Engler & Engler 2006). Procyanidins (oligomers) 
are thought to accumulate at the liposome surface of cells and prevent the 
access of deleterious molecules inside the cell. The monomers catechin 
and epicatechin, and some dimers with epicatechin subunits are able to 
diffuse into the cells and affect enzymes and signalling cascades (Keen et 
al 2005). 
5.3 Anti-inflammatory effect 
Increasingly the endothelium is becoming considered as a vital organ in 
cardiovascular health. Dysfunction of the endothelium is often a result of 
the activation of proinflammatory enzyme systems through the production 
of reactive oxygen species (ROS) and radicals. Nuclear transcription factor 
(NFKB) binds to the promoter regions of genes coding for pro-
inflammatory proteins. Nitric oxide (NO) is a molecule required for 
vasodilation and normally inhibits NFKB synthesis. However, oxidative 
stress and endothelial dysfunction reduce the bioavailability of NO, and 
intracellular ROS accumulate and NFKB is activated. Catechin and 
epicatechin have been found to stimulate the production of NO, and 
suppress the production of proinflammatory cytokines while enhancing 
7 
 
the production of anti-inflammatory cytokines. They also inhibit NO-
related nitration and oxidation reactions and prevent the activation of 
NFKB (Engler & Engler 2006). Epicatechin in particular has been shown to 
have the more prominent role, and is also involved in the scavenging of 
free radicals and maintenance of the enzyme nitric oxide synthase for NO 
synthesis (Steffen, Schewe & Sies 2005). 
 
A six week study on overweight adults found that consumption of cocoa 
led to an improvement in endothelial function, observed by measuring 
flow mediated dilation (FMD) (Njike et al 2011). Sweetened and non-
sweetened cocoa were tested but the difference between the two were 
statistically insignificant. Heiss et al (2005) found that just a single dose of 
a high polyphenol cocoa drink was enough to increase levels of circulating 
NO and FMD, and studies testing single doses of dark chocolate also 
showed similar results (Hermann et al 2003, Vlachopulos et al 2005). The 
improvement is attributed to the flavanols which activate nitric oxide 
synthase, which then produce nitric oxide and induce vasodilation. Studies 
focusing on blood pressure showed correlations between chocolate 
consumption and decreases in both systolic and diastolic blood pressure 
(Ellinger et al 2012, Taubert et al 2003). This agrees with a study 
conducted on 14 healthy overweight and obese individuals, where 
consumption of dark chocolate containing 500mg and 1000mg of 
polyphenol lowered blood glucose levels and blood pressure (Almoosawi 
et al 2010). However there was not a significant difference between 
500mg and 1000mg, suggesting that the effect plateaus after a certain 
amount of polyphenols, or after a particular blood pressure level. 
Chocolate may not lower blood pressure drastically, but it may be 
effective to combine chocolate consumption with other lifestyle changes 
such as exercise.  
5.4 Anti-platelet effect 
The formation of platelets is vital in the blood-clotting process when the 
blood vessels are damaged, but now is increasingly associated with heart 
attacks, strokes, and the progression of atherothrombosis. Plaques can 
build up in the vessels as a result of smoking, high blood pressure and 
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cholesterol, and the rupturing of these activates platelet aggregation and 
blood-clotting. Since there is no actual damage to the blood vessel, the 
blood-clot ends up blocking the blood flow (Ueno et al 2011).  
A small scale study on 20 smokers showed that consumption of dark 
chocolate-but not white chocolate-reduced platelet activation (Hermann 
et al 2006). Cocoa is thought to reduce platelet aggregation by producing 
prostacyclin, a molecule that inhibits this process and induces vasodilation. 
NO (synthesised with the aid of catechin and epicatechin) is also involved 
in the inhibition process. This has been shown in in vivo studies where 
decreases in platelet activation and aggregation from cocoa consumption, 
correlate with increases in plasma epicatechin concentrations (Pearson et 
al 2002). Plasma prostacyclin levels were seen to increase by 32% 
following the consumption of high procyanidin chocolate (Schramm et al 
2001). A single dose of semi-sweet chocolate chips was shown to increase 
the prostacyclin-leukotriene ratio and reduce platelet related haemostasis 
(Holt et al 2002). Leukotrienes are chemicals synthesised through the 
metabolism of arachidonic acid, and are important for antimicrobial 
defence. However they are proinflammatory, can stimulate platelet 
aggregation and induce vasoconstriction (Ding et al 2006). They are 
involved in the growth of artherosclerotic vascular lesions, and have been 
linked to strokes and myocardial infarctions (Peters-Golden & Henderson 
2007).  
 
5.5 Flavanol bioavailability 
 
Not only is the mechanism of the flavanols unclear, the amount flavanols 
present in the final chocolate product is unknown unless each type is 
tested individually. This is because a significant amount of the flavanols 
can be lost during processing. A common method of producing cocoa 
powder is called Dutch Processing. It is an alkalising process that 
neutralises the acid and can result in a loss of up to 90% of the flavanols 
contained in cocoa (Miller et al 2008). An interesting study was conducted 
by Hurst et al. (2011) where the impact of common processes on flavanol 
stereochemistry of cocoa beans was observed. They concluded that (+)-
catechin and (-)-epicatechin levels were reduced through fermentation, 
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drying, roasting and Dutch Processing, however there were increases in (-
)-catechin.  We cannot be sure whether the losses can be accounted for by 
the gains made, as the different ways in which each isomer works in 
unclear. It has been found however, that the preferred order of absorption 
is (-)-epicatechin > (+)-catechin > (-)-catechin.  
A solution may be to omit these processes but it is not as simple as they 
improve palatability by removing the astringency, and increase 
microbiological safety through sterilisation. Currently there is work being 
put into retaining as much of the flavanol content as possible. Trials on a 
polyphenol-rich cocoa powder have been undertaken and shown positive 
results (Schinella et al 2010), and modification of the beans is also being 
looked into in Ghana (). It is also important to educate consumers as 
handling methods at home can affect flavanol levels. Stahl et al (2009) 
found that chocolate cake baked using baking powder retains a much 
higher level of flavanols compared to that made using baking soda due to 
the differences in the way they affect pH. Baking soda increases the pH of 
the cake more than baking powder, and a pH above 7.5 was noted as 
resulting in significant losses of flavanols. 
 
 
6. Other  effects  
6.1 Lipid effect 
Numerous studies observing the effects on lipid content have been 
conducted and a variety of results have been recorded. There are two 
major types of cholesterol; low-density lipoproteins (LDL) and high-density 
lipoproteins (HDL). LDL is the “bad” cholesterol as it can build up and 
stiffen the arterial walls, causing atherosclerosis. HDL is the “good” 
cholesterol as it carries cholesterol away from the arteries, lowering the 
risks of heart disease (American Heart Association 2012).  
Wan et al (2001) in a four week study, found that individuals consuming 
regular amounts of either dark chocolate or cooca powder had a 4% 
increase in HDL on average compared to those without.  Mursu et al 
(2004) found dark chocolate enriched with polyphenols to increase levels 
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of serum HDL by nearly 14%, and even dark chocolate by 11%, while white 
chocolate actually led to a slight decrease in HDL. Interestingly, they also 
found that all three types of chocolate led to a decrease in LDL 
peroxidation. Since white chocolate does not contain cocoa mass, this is 
thought to be due to the fatty acids present in cocoa butter. The inhibition 
of lipid peroxidation from monounsaturated fats, such as oleic acid found 
in cocoa butter has been found in previous studies (Eritsland 2000).  
A study using rats found that regular intake of cocoa significantly 
decreased the levels of plasma cholesterol (Osakabe & Yamagishi 2009). 
The suggested reason for this is that the procyanidins in cocoa inhibit the 
intestinal absorption of cholesterol. Matsui et al (2005) observed an 
association between chocolate and weight loss, and suggested that 
flavanols supress the expression of LDL gene receptors and inhibit fatty 
acid synthesis. It is difficult to directly compare the studies however due to 
the different methods used. Greater increases in HDL levels may simply be 
due to the greater amount of cocoa administered for example.  
6.2 Psychological effects 
For some people eating chocolate can have positive psychological effects 
by lifting their moods. Dieting and cutting back on confectionery often 
leads to stress, and stress is a major factor in the development of 
cardiovascular diseases. Chocolate is often called a “comfort food” and can 
improve the mood immediately, possibly by directly affecting the brain 
neurotransmitters (Macht & Mueller 2007). A study on over 1300 men 
with an average age of 76 concluded that chocolate was associated not 
only with better health but also optimism and psychological well-being 
(Strandberg et al 2008). 
 
6.3 Anti-cariogenic effect 
 
Cocoa bean husk extracts (CBHE) have been found to have anti-cariogenic 
properties. CBHE are the by-products of cocoa processing and contain high 
levels of polyphenols. Streptococcus mutans and Streptococcus sanguinis 
are two types of oral bacteria that contribute to plaque formation and acid 
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production, subsequently leading to the formation of caries (Ferrazzano et 
al 2009). Cocoa polyphenols were found to inhibit biofilm and acid 
production in experiments conducted in vitro (Percival et al 2006). In vivo 
experiments testing mouthwash containing CBHE found that they were 
effective in lowering the counts of Streptococci and overall plaque 
formation (Srikanth, Shashikiran & Subba Reddy 2008). It is important to 
note that cocoa mass found in commercial chocolate does not have the 
same properties, and eating large amounts of chocolate will not have the 
same effect. It is an interesting field of research however that is worth 
looking into. There are benefits not only from the dental point of view, but 
also from an economic point of view looking at the efficient use of by-
products  
 
6.4 Role of stearic acid 
The fatty acids contained in chocolate are also a topic of interest, 
especially stearic acid as it may affect cholesterol and lipoprotein levels. 
Cocoa butter is contains on average 33% oleic acid (monounsaturated fat), 
33% stearic acid and 25% is palmitic acid (both saturated fats) (Tokede, 
Gaziano & Djoussé 2011). Stearic acid has been found to have anti-platelet 
effects and reduce blood pressure according to some studies (Grassi et al 
2005). This could be due to its chain length (stearic acid is 18:0 so a long-
chain fatty aicd) and poor absorption, or it could be that it becomes 
desaturated into oleic acid -a fat that protects against CHD-upon digestion. 
Others claim that it has no such effects. They suggest that stearic acid is 
cholesterol neutral and has no effect on HDL or LDL levels (Kris-Etherton & 
Yu 1997). Studying the effects of stearic acid is difficult as it is not the only 
fatty acid present. It will interact with other fatty acids and may, as 
suggested, convert into other types. But either way there appears to be no 
research concluding that stearic acid has substantially negative impacts on 
health or cardiovascular health. Recently however, manufacturers are 
increasingly trying to substitute cocoa butter with healthier vegetable fats, 
but as mentioned before there are strict regulations regarding the types 
and amounts of ingredients used. 
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7. Looking into the future 
Before any recommended daily intake values are given for chocolate it is 
necessary to become clear of their exact mechanisms and how they are 
metabolised. Commercial chocolate is high in calories, so will not have the 
same effects as polyphenol-rich chocolate made specifically for studies. A 
Swedish study involving middle-aged and elderly women found that 
consumption of chocolate 1-3 times per month or 1-2 times per week 
correlated with lower incidences of heart failure (Mostofsky 2010). 
However the incidences were higher in those consuming 3-6 servings per 
week and 1 or more servings per day, similar to the prevalence in those 
consuming no chocolate at all (the average serving size was 30g for those 
≤61 years and 19g for those ≥62 years). This shows that excessive amounts 
of chocolate can have negative impacts, and further highlights the need 
for more information regarding effective dosages of flavanols and 
educating the public. 
The experimental methods may need to be reviewed. For example there 
are a number of different ways to test the antioxidant activity of foods in 
vitro, and it has been found that they do not always give the same results 
(Pastoriza et al 2011). A standardised method to be used around the world 
will make comparisons easier, or at least some information clearly 
outlining each method would be helpful.  
As mentioned before, the bioavailability of the flavanols are greatly 
affected by processing, and each manufacturer should be responsible for 
assessing their products. Manufacturing processes may need to be 
reviewed or changed depending on how much of the flavanols are lost.  
Since chocolate varies so much around the world it may be useful to have 
some common standards. An indication of polyphenol content on the 
packaging for example, may help consumers during selection. 
Currently manufacturers are trying to create new, healthier types of 
chocolate focusing on different aspects. As chocolate is still high in calories 
efforts are being made to reduce the sugar content. Cocoa beans 
containing greater amounts of polyphenols and cocoa powder that retains 
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high levels of polyphenols even after processing (Schinella et al 2010) are 
being looked into as well as cocoa butter alternatives and lower fat 
contents (Bootello et al 2012).  
 
8. Conclusion 
The vast amount of epidemiological evidence gathered from around the 
world means that we can be fairly confident in saying that chocolate 
contributes to cardiovascular health. Overall there appear to be three 
main ways in which flavanols in chocolate contribute to cardiovascular 
health: 
1. They act as antioxidants by increasing the total plasma antioxidant 
capacity and reducing LDL susceptibility to oxidation.  
2. They have an anti-inflammatory effect mainly through the 
stimulation of NO production 
3. Platelet aggregation can be reduced contributing to healthy 
endothelial function.  
There is also the possible contribution of stearic acid. Although it is 
becoming apparent that chocolate is beneficial to our health, it is 
important to remember that not all chocolate is the same. The origin of 
the beans and the production methods greatly affect the quality of the 
final product. The bioavailability of the polyphenols change depending on 
the production technique, and are actually often destroyed with 
processing. So the amount of cocoa contained in the final product cannot 
be used as an indication for the amount of polyphenols or flavanols it 
contains. Many popular chocolate bars have nuts, wafers, caramel etc. 
changing the amount of cocoa contained per weight, so it is difficult to 
give recommendations on how much we should be consuming. Also most 
of the research so far has only been conducted in vitro, or in vivo on a very 
small scale. Large scale studies concerning humans are usually through 
surveys, relying on individual honesty.  
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It is important to remember that although beneficial for cardiovascular 
health chocolate is by no means a cure for cardiovascular diseases. It is not 
always effective in those already with high risk factors, and greater 
lifestyle changes in diet and habits are required for improvement. It can 
also have a high sugar and caloric content so as with all things, should be 
taken in moderation. 
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